13 Jul 2024

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

FluoGuide A/S presents at BioStock Live

Press release

October 14, 2020

Copenhagen, Denmark, 14 October 2020 – FluoGuide A/S (“FluoGuide” or “the Company”) presents at BioStock Live on Thursday 15 October 2020 at 12.00 CEST.

Together with four other Life Science companies, FluoGuide will present at BioStock Live from their studio at Medicon Village in Lund to talk about the Company’s ongoing clinical trial of its lead product FG001, which will commence with a site inspection by the Danish Medicine Agency. The detailes about the clinical trial is presented in the interim report from Q2-2020 (page 6) released on 14 August 2020.

The event starts at 10:00 CEST and FluoGuide will begin presenting at 12:00 CEST. Please follow this link to watch the presentations. You can sign up for BioStock’s newsletter (sign up) to receive a reminder for the event as well as other Life Science news